# FDA Inspection 1164181 - North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding - March 10, 2022

Source: https://www.keypedia.com/records/fda_inspections/north-american-custom-laboratories-llc-dba-farmakeio-superior-custom-compounding/06a65fad-a980-4edf-ba27-27c5b321af49
Source feed: FDA_Inspections

> FDA Inspection 1164181 for North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding on March 10, 2022. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1164181
- Company Name: North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding
- Inspection Date: 2022-03-10
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1280796 - 2025-09-05](https://www.keypedia.com/records/fda_inspections/north-american-custom-laboratories-llc-dba-farmakeio-superior-custom-compounding/c27b65d6-4ba0-4c25-8c22-7de5cfd3de16)

Company: https://www.keypedia.com/companies/north-american-custom-laboratories-llc-dba-farmakeio-superior-custom-compounding/7c4b92d9-254c-4973-a722-4afe9513f3d6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c